HCC-based transplants straining donor pool
The increase in the number of hepatocellular carcinoma patients in the U.S. being wait-listed for transplant is leading to a greater incidence of wait-listing for all individuals with hepatitis C, a speaker said. "The demand for liver transplantation for hepatocellular carcinoma is likely going to continue to rise and further strain our already limited donor pool," Dr. Jennifer A. Flemming, FRCP(C), MAS, of the University of California at San Francisco, said at The Liver Meeting. "This could influence HCC listing policy over the next decade and may push the transplant community to consider nontransplant alternatives [for HCC patients]."
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063